Suppr超能文献

相似文献

1
The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2).
Br J Pharmacol. 2007 May;151(2):163-74. doi: 10.1038/sj.bjp.0707218. Epub 2007 Mar 20.
4
Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.
Chin J Cancer. 2012 Feb;31(2):73-99. doi: 10.5732/cjc.011.10320. Epub 2011 Nov 18.
6
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.
Biochem Pharmacol. 2012 Apr 15;83(8):1084-103. doi: 10.1016/j.bcp.2012.01.002. Epub 2012 Jan 11.
7
Role of the breast cancer resistance protein (ABCG2) in drug transport.
AAPS J. 2005 May 11;7(1):E118-33. doi: 10.1208/aapsj070112.
8
The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2.
Mol Cancer Ther. 2012 Sep;11(9):2033-44. doi: 10.1158/1535-7163.MCT-12-0302. Epub 2012 Jul 9.
9
Overlapping substrate and inhibitor specificity of human and murine ABCG2.
Drug Metab Dispos. 2013 Oct;41(10):1805-12. doi: 10.1124/dmd.113.053140. Epub 2013 Jul 18.

引用本文的文献

1
Population pharmacokinetics of high-dose methotrexate in patients with primary central nervous system lymphoma.
Front Pharmacol. 2025 May 19;16:1578033. doi: 10.3389/fphar.2025.1578033. eCollection 2025.
2
Ultrasounds in cancer therapy: A summary of their use and unexplored potential.
Oncol Rev. 2022 Feb 22;16(1):531. doi: 10.4081/oncol.2022.531.
5
Can trophectoderm RNA analysis predict human blastocyst competency?
Syst Biol Reprod Med. 2019 Aug;65(4):312-325. doi: 10.1080/19396368.2019.1625085. Epub 2019 Jun 27.
6
The contribution of G34A and C421A polymorphisms to multiple myeloma susceptibility.
Onco Targets Ther. 2019 Feb 27;12:1655-1660. doi: 10.2147/OTT.S195245. eCollection 2019.
7
8
Lack of ABCG2 Leads to Biventricular Dysfunction and Remodeling in Response to Hypoxia.
Front Physiol. 2017 Feb 21;8:98. doi: 10.3389/fphys.2017.00098. eCollection 2017.
9
ATP-dependent substrate transport by the ABC transporter MsbA is proton-coupled.
Nat Commun. 2016 Aug 8;7:12387. doi: 10.1038/ncomms12387.

本文引用的文献

1
Purification and 3D structural analysis of oligomeric human multidrug transporter ABCG2.
Structure. 2006 Nov;14(11):1623-32. doi: 10.1016/j.str.2006.08.014.
2
Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.
Physiol Rev. 2006 Oct;86(4):1179-236. doi: 10.1152/physrev.00037.2005.
3
ATP-binding cassette, subfamily G (ABCG family).
Pflugers Arch. 2007 Feb;453(5):735-44. doi: 10.1007/s00424-006-0134-x. Epub 2006 Sep 16.
4
Multiple drugbinding sites on the R482G isoform of the ABCG2 transporter.
Br J Pharmacol. 2006 Nov;149(5):506-15. doi: 10.1038/sj.bjp.0706904. Epub 2006 Sep 18.
5
Purification of breast cancer resistance protein ABCG2 and role of arginine-482.
Cell Mol Life Sci. 2006 Aug;63(16):1912-22. doi: 10.1007/s00018-006-6159-7.
7
Metabolites of ginsenosides as novel BCRP inhibitors.
Biochem Biophys Res Commun. 2006 Jul 14;345(4):1308-14. doi: 10.1016/j.bbrc.2006.04.152. Epub 2006 May 4.
8
New light on multidrug binding by an ATP-binding-cassette transporter.
Trends Pharmacol Sci. 2006 Apr;27(4):195-203. doi: 10.1016/j.tips.2006.02.008. Epub 2006 Mar 20.
9
Targeting multidrug resistance in cancer.
Nat Rev Drug Discov. 2006 Mar;5(3):219-34. doi: 10.1038/nrd1984.
10
Modulation of p-glycoprotein and breast cancer resistance protein by some prescribed corticosteroids.
Eur J Pharmacol. 2006 Feb 15;531(1-3):25-33. doi: 10.1016/j.ejphar.2005.12.010. Epub 2006 Jan 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验